Follow-The-Filings

ASND position history

The shares of Ascendis Pharma A/S (ASND) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity · SPONSORED ADR

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q4 · 11,000 shares · $1M · 0.37% of portfolio · New
  2. 2022 Q1 · 30,612 shares · $4M · 0.94% of portfolio · Add +178.3%
  3. 2022 Q2 · 139,212 shares · $13M · 3.5% of portfolio · Add +354.8%
  4. 2022 Q3 · 135,712 shares · $14M · 3.8% of portfolio · Reduce −2.5%
  5. 2022 Q4 · 130,212 shares · $16M · 4.5% of portfolio · Reduce −4.1%
  6. 2023 Q1 · 135,212 shares · $14M · 4.3% of portfolio · Add +3.8%
  7. 2023 Q2 · 135,212 shares · $12M · 3.3% of portfolio
  8. 2023 Q3 · 136,212 shares · $13M · 4.0% of portfolio · Add +0.7%
  9. 2023 Q4 · 123,472 shares · $16M · 3.7% of portfolio · Reduce −9.4%
  10. 2024 Q1 · 92,472 shares · $14M · 3.2% of portfolio · Reduce −25.1%
  11. 2024 Q2 · 80,972 shares · $11M · 2.6% of portfolio · Reduce −12.4%
  12. 2024 Q3 · 89,572 shares · $13M · 3.2% of portfolio · Add +10.6%
  13. 2024 Q4 · 103,355 shares · $14M · 3.6% of portfolio · Add +15.4%
  14. 2025 Q1 · 80,398 shares · $13M · 3.6% of portfolio · Reduce −22.2%
  15. 2025 Q2 · 72,677 shares · $13M · 3.5% of portfolio · Reduce −9.6%
  16. 2025 Q3 · 33,177 shares · $7M · 1.6% of portfolio · Reduce −54.4%
  17. 2025 Q4 · 28,177 shares · $6M · 1.4% of portfolio · Reduce −15.1%
  18. 2026 Q1 · 23,177 shares · $5M · 1.2% of portfolio · Reduce −17.7%
  19. 2026 Q2 · not held · Exit
Holdings date Value % of holdings Shares Filing date All 13F holders